Johnson & Johnson's Q2 sales up 9%

Jul 17, 2008 (Datamonitor via COMTEX) -- JNJ | Quote | Chart | News | PowerRating -- Johnson & Johnson, a healthcare and personal care company, has reported sales of $16.5 billion for the second quarter of 2008, an increase of 8.7%, compared to $15.13 billion in the second quarter of 2007.

Net earnings and diluted earnings per share for the second quarter of 2008 were $3.3 billion and $1.17, respectively. For the second quarter of 2007, net income was $3.08 billion, or $1.05 per diluted share.

For the first six months of 2008, sales were $32.64 billion, an increase of 8.2%, compared to $30.17 billion in the corresponding period of 2007. Net earnings stood at $6.92 billion, or $2.43 per diluted share, compared to $5.65 billion, or $1.93 per diluted share, in the same period of 2007.

William Weldon, chairman and CEO of Johnson & Johnson, said: "Our solid earnings this quarter build on our strong track record of performance. We are successfully managing through short-term pressures while continually making progress to enhance our long-term growth."

http://www.datamonitor.com

Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index